Categories: Automobile

Hyundai Motor Group Tops Rankings in 2025 IIHS Top Safety Awards

  • Hyundai Motor Group Earns 15 IIHS Top Safety Awards Across Hyundai, Kia and Genesis Brands
  • Most TSP and TSP+ Ratings Among All Automotive Groups for Second Consecutive Year
  • Recognized for Excellence in Rear Occupant Protection Under Stricter 2025 IIHS Criteria

Hyundai Motor Group (the Group) has reaffirmed its leadership in vehicle safety, achieving the highest number of models awarded in the 2025 Insurance Institute for Highway Safety (IIHS) crash test evaluations.

- Advertisement -

A total of 15 models across Hyundai Motor Company, Kia Corporation and Genesis have earned either 2025 TOP SAFETY PICK (TSP) or TOP SAFETY PICK+ (TSP+) designation. This includes seven Hyundai models, five Genesis models, and three Kia models, marking the second consecutive year the Group has received the most IIHS safety awards.

- Advertisement -

In the latest round of evaluations, the 2025 Hyundai ELANTRA, SONATA and 2025 Kia K4, were awarded the coveted TSP+ rating, joining existing models such as the 2025 Hyundai IONIQ 5, IONIQ 6, KONA, TUCSON, and SANTA FE; the Genesis GV60, Electrified GV70, GV70, GV80; and the 2025 Kia EV9 and Telluride. The 2025 Genesis G90 currently holds a TSP rating.

- Advertisement -

The IIHS enhanced its crash test criteria for 2025, introducing more stringent requirements for second-row occupant protection. In the updated moderate overlap front test, dummies representing 12-year-old children or small female passengers are placed in the rear seats to assess injury risk more realistically. To qualify for a TSP+ rating, vehicles must now earn a “good” rating in this test, while a rating of “acceptable” is required for TSP.

- Advertisement -

To earn a 2025 TSP or TSP+ rating, vehicles must also:

- Advertisement -
  • Earn “good” ratings in both the small overlap front and updated side impact crash tests
  • Receive at least an “acceptable” rating in daytime and nighttime pedestrian front crash prevention evaluations
  • Be equipped, across all trim levels, with headlights rated “acceptable” or better

The Insurance Institute for Highway Safety (IIHS) is an independent, nonprofit scientific and educational organization dedicated to reducing deaths, injuries and property damage from motor vehicle crashes through research and evaluation and through education of consumers, policymakers and safety professionals. Its TSP and TSP+ ratings are widely cited in the North American auto industry by consumers, media and analysts alike.

- Advertisement -

[Table] 2025 IIHS TSP+ / TSP Ratings for Hyundai Motor Group (Total 15 models)

- Advertisement -

Company

Model (MY2025)

Award

Hyundai Motor Company

(Seven models awarded TSP+)

ELANTRA

(built after October 2024)

TSP+

SONATA

(built after November 2024)

IONIQ 5

IONIQ 6

KONA

TUCSON

SANTA FE

(built after November 2024)

Genesis

(Four models awarded TSP+,

One model awarded TSP)

GV60

TSP+

Electrified GV70

GV70

(built after April 2024)

GV80

G90

TSP

Kia Corporation

(Three models awarded TSP+)

K4

(built after January 2025)

TSP+

EV9

Telluride

TheNews Market

Recent Posts

Kia PV5 Cargo Achieves Maximum FiveStar Rating in 2025 Euro NCAP Commercial Van Safety Assessment

Kia PV5 Cargo earns the top five-star rating in the 2025 Euro NCAP Commercial Van…

9 minutes ago

Kia Launches Inspiration Connects Us All Campaign Ahead of FIFA World Cup 2026

New campaign highlights Kia’s commitment to promoting unity and connection for people around the worldKia…

9 minutes ago

Menarini Group Presents Elacestrant (ORSERDU) Phase 2 Combination Data in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2025 San Antonio Breast Cancer Symposium

In addition, the expansive elacestrant clinical development program updates reinforce its potential as a backbone endocrine…

1 hour ago

Manipal Hospitals Enhances Movement and Confidence Through Awareness on Movement Disorders

BENGALURU, India, Dec. 8, 2025 /PRNewswire/ -- Parkinson's disease often begins far more quietly than…

1 hour ago

UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduces countable motor seizure frequency in CDKL5 Deficiency Disorder

Seizure reduction: phase 3 study achieved primary endpoint as fenfluramine demonstrated a statistically significant reduction…

1 hour ago

Investment of Approx. USD 460,000 for the Development of a Prototype Mpox Detection Test with NIPRO, TBA, Japan Institute for Health Security and others

TOKYO, Dec. 8, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today an investment…

1 hour ago